 | • レポートコード：MRC2-11QY04907 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍マーカーイムノアッセイのグローバル市場について調査・分析したレポートです。種類別（ProGRP、PSA（複合体、遊離、合計））、SCC（扁平上皮癌抗原）、血清HER-2 / neu、サイログロブリン、CA 72-4、その他）市場規模、用途別（肝臓がん、乳がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍マーカーイムノアッセイの競争状況、市場シェア ・世界の腫瘍マーカーイムノアッセイ市場：種類別市場規模 2015年-2020年（ProGRP、PSA（複合体、遊離、合計））、SCC（扁平上皮癌抗原）、血清HER-2 / neu、サイログロブリン、CA 72-4、その他） ・世界の腫瘍マーカーイムノアッセイ市場：種類別市場規模予測 2021年-2026年（ProGRP、PSA（複合体、遊離、合計））、SCC（扁平上皮癌抗原）、血清HER-2 / neu、サイログロブリン、CA 72-4、その他） ・世界の腫瘍マーカーイムノアッセイ市場：用途別市場規模 2015年-2020年（肝臓がん、乳がん、その他） ・世界の腫瘍マーカーイムノアッセイ市場：用途別市場規模予測 2021年-2026年（肝臓がん、乳がん、その他） ・北米の腫瘍マーカーイムノアッセイ市場分析：米国、カナダ ・ヨーロッパの腫瘍マーカーイムノアッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍マーカーイムノアッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍マーカーイムノアッセイ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍マーカーイムノアッセイ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Clarity Diagnostics, LLC、CTK Biotech, Inc、DIALAB GmbH、Ortho Clinical Diagnostics、Polymedco, Inc、DIAsource ImmunoAssays SA、DRG International, Inc、Fujirebio US, Inc、Bioscience (Tianjin) Diagnostic Technology Co., Ltd、Boson Biotech Co., Ltd、Qualigen, Inc、Randox Laboratories, Ltd、Roche Diagnostic Corporation、Siemens Healthineers、Syntron Bioresearch, Inc、Teco Diagnostics、Thermo Fisher Scientific, Inc、Tosoh Bioscience, Inc、Diametra、DiaSorin S.p.A ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Tumor Markers Immunoassay Market
The global Tumor Markers Immunoassay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tumor Markers Immunoassay Scope and Market Size
Tumor Markers Immunoassay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Markers Immunoassay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A
Market segment by Type, the product can be split into
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others
Market segment by Application, split into
Liver Cancer
Breast Cancer
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
1.4 Market by Type
1.4.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ProGRP
1.4.3 PSA (complexed, free, total))
1.4.4 SCC (squamous cell carcinoma antigen)
1.4.5 Serum HER-2/neu
1.4.6 Thyroglobulin
1.4.7 CA 72-4
1.4.8 Others
1.5 Market by Application
1.5.1 Global Tumor Markers Immunoassay Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Breast Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2015-2026)
2.2 Global Tumor Markers Immunoassay Growth Trends by Regions
2.2.1 Tumor Markers Immunoassay Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Markers Immunoassay Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Markers Immunoassay Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Markers Immunoassay Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Market Size
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2015-2020)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Markers Immunoassay Market Concentration Ratio
3.2.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2019
3.3 Tumor Markers Immunoassay Key Players Head office and Area Served
3.4 Key Players Tumor Markers Immunoassay Product Solution and Service
3.5 Date of Enter into Tumor Markers Immunoassay Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2015-2020)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tumor Markers Immunoassay Market Size by Application (2015-2020)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2015-2020)
6.2 Tumor Markers Immunoassay Key Players in North America (2019-2020)
6.3 North America Tumor Markers Immunoassay Market Size by Type (2015-2020)
6.4 North America Tumor Markers Immunoassay Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2015-2020)
7.2 Tumor Markers Immunoassay Key Players in Europe (2019-2020)
7.3 Europe Tumor Markers Immunoassay Market Size by Type (2015-2020)
7.4 Europe Tumor Markers Immunoassay Market Size by Application (2015-2020)
8 China
8.1 China Tumor Markers Immunoassay Market Size (2015-2020)
8.2 Tumor Markers Immunoassay Key Players in China (2019-2020)
8.3 China Tumor Markers Immunoassay Market Size by Type (2015-2020)
8.4 China Tumor Markers Immunoassay Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tumor Markers Immunoassay Market Size (2015-2020)
9.2 Tumor Markers Immunoassay Key Players in Japan (2019-2020)
9.3 Japan Tumor Markers Immunoassay Market Size by Type (2015-2020)
9.4 Japan Tumor Markers Immunoassay Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tumor Markers Immunoassay Market Size (2015-2020)
10.2 Tumor Markers Immunoassay Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Markers Immunoassay Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Markers Immunoassay Market Size by Application (2015-2020)
11 India
11.1 India Tumor Markers Immunoassay Market Size (2015-2020)
11.2 Tumor Markers Immunoassay Key Players in India (2019-2020)
11.3 India Tumor Markers Immunoassay Market Size by Type (2015-2020)
11.4 India Tumor Markers Immunoassay Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tumor Markers Immunoassay Market Size (2015-2020)
12.2 Tumor Markers Immunoassay Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Markers Immunoassay Market Size by Type (2015-2020)
12.4 Central & South America Tumor Markers Immunoassay Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Clarity Diagnostics, LLC
13.1.1 Clarity Diagnostics, LLC Company Details
13.1.2 Clarity Diagnostics, LLC Business Overview
13.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
13.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2015-2020))
13.1.5 Clarity Diagnostics, LLC Recent Development
13.2 CTK Biotech, Inc
13.2.1 CTK Biotech, Inc Company Details
13.2.2 CTK Biotech, Inc Business Overview
13.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
13.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.2.5 CTK Biotech, Inc Recent Development
13.3 DIALAB GmbH
13.3.1 DIALAB GmbH Company Details
13.3.2 DIALAB GmbH Business Overview
13.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
13.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.3.5 DIALAB GmbH Recent Development
13.4 Ortho Clinical Diagnostics
13.4.1 Ortho Clinical Diagnostics Company Details
13.4.2 Ortho Clinical Diagnostics Business Overview
13.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
13.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.4.5 Ortho Clinical Diagnostics Recent Development
13.5 Polymedco, Inc
13.5.1 Polymedco, Inc Company Details
13.5.2 Polymedco, Inc Business Overview
13.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
13.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.5.5 Polymedco, Inc Recent Development
13.6 DIAsource ImmunoAssays SA
13.6.1 DIAsource ImmunoAssays SA Company Details
13.6.2 DIAsource ImmunoAssays SA Business Overview
13.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
13.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.6.5 DIAsource ImmunoAssays SA Recent Development
13.7 DRG International, Inc
13.7.1 DRG International, Inc Company Details
13.7.2 DRG International, Inc Business Overview
13.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
13.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.7.5 DRG International, Inc Recent Development
13.8 Fujirebio US, Inc
13.8.1 Fujirebio US, Inc Company Details
13.8.2 Fujirebio US, Inc Business Overview
13.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
13.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.8.5 Fujirebio US, Inc Recent Development
13.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
13.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
13.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
13.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
13.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
13.10 Boson Biotech Co., Ltd
13.10.1 Boson Biotech Co., Ltd Company Details
13.10.2 Boson Biotech Co., Ltd Business Overview
13.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
13.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
13.10.5 Boson Biotech Co., Ltd Recent Development
13.11 Qualigen, Inc
10.11.1 Qualigen, Inc Company Details
10.11.2 Qualigen, Inc Business Overview
10.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
10.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.11.5 Qualigen, Inc Recent Development
13.12 Randox Laboratories, Ltd
10.12.1 Randox Laboratories, Ltd Company Details
10.12.2 Randox Laboratories, Ltd Business Overview
10.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
10.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.12.5 Randox Laboratories, Ltd Recent Development
13.13 Roche Diagnostic Corporation
10.13.1 Roche Diagnostic Corporation Company Details
10.13.2 Roche Diagnostic Corporation Business Overview
10.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
10.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.13.5 Roche Diagnostic Corporation Recent Development
13.14 Siemens Healthineers
10.14.1 Siemens Healthineers Company Details
10.14.2 Siemens Healthineers Business Overview
10.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
10.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.14.5 Siemens Healthineers Recent Development
13.15 Syntron Bioresearch, Inc
10.15.1 Syntron Bioresearch, Inc Company Details
10.15.2 Syntron Bioresearch, Inc Business Overview
10.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
10.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.15.5 Syntron Bioresearch, Inc Recent Development
13.16 Teco Diagnostics
10.16.1 Teco Diagnostics Company Details
10.16.2 Teco Diagnostics Business Overview
10.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
10.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.16.5 Teco Diagnostics Recent Development
13.17 Thermo Fisher Scientific, Inc
10.17.1 Thermo Fisher Scientific, Inc Company Details
10.17.2 Thermo Fisher Scientific, Inc Business Overview
10.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
10.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.17.5 Thermo Fisher Scientific, Inc Recent Development
13.18 Tosoh Bioscience, Inc
10.18.1 Tosoh Bioscience, Inc Company Details
10.18.2 Tosoh Bioscience, Inc Business Overview
10.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
10.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.18.5 Tosoh Bioscience, Inc Recent Development
13.19 Diametra
10.19.1 Diametra Company Details
10.19.2 Diametra Business Overview
10.19.3 Diametra Tumor Markers Immunoassay Introduction
10.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.19.5 Diametra Recent Development
13.20 DiaSorin S.p.A
10.20.1 DiaSorin S.p.A Company Details
10.20.2 DiaSorin S.p.A Business Overview
10.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
10.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2015-2020)
10.20.5 DiaSorin S.p.A Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tumor Markers Immunoassay Key Market Segments
Table 2. Key Players Covered: Ranking by Tumor Markers Immunoassay Revenue
Table 3. Ranking of Global Top Tumor Markers Immunoassay Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tumor Markers Immunoassay Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ProGRP
Table 6. Key Players of PSA (complexed, free, total))
Table 7. Key Players of SCC (squamous cell carcinoma antigen)
Table 8. Key Players of Serum HER-2/neu
Table 9. Key Players of Thyroglobulin
Table 10. Key Players of CA 72-4
Table 11. Key Players of Others
Table 12. Global Tumor Markers Immunoassay Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Tumor Markers Immunoassay Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Tumor Markers Immunoassay Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Tumor Markers Immunoassay Market Share by Regions (2015-2020)
Table 16. Global Tumor Markers Immunoassay Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Tumor Markers Immunoassay Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Tumor Markers Immunoassay Market Growth Strategy
Table 22. Main Points Interviewed from Key Tumor Markers Immunoassay Players
Table 23. Global Tumor Markers Immunoassay Revenue by Players (2015-2020) (Million US$)
Table 24. Global Tumor Markers Immunoassay Market Share by Players (2015-2020)
Table 25. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Markers Immunoassay as of 2019)
Table 26. Global Tumor Markers Immunoassay by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Tumor Markers Immunoassay Product Solution and Service
Table 29. Date of Enter into Tumor Markers Immunoassay Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 32. Global Tumor Markers Immunoassay Market Size Share by Type (2015-2020)
Table 33. Global Tumor Markers Immunoassay Revenue Market Share by Type (2021-2026)
Table 34. Global Tumor Markers Immunoassay Market Size Share by Application (2015-2020)
Table 35. Global Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 36. Global Tumor Markers Immunoassay Market Size Share by Application (2021-2026)
Table 37. North America Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 39. North America Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 40. North America Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 41. North America Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 42. North America Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 43. Europe Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 45. Europe Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 47. Europe Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 49. China Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 50. China Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 51. China Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 52. China Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 53. China Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 54. China Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 55. Japan Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 57. Japan Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 59. Japan Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 63. Southeast Asia Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 65. Southeast Asia Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 67. India Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 68. India Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 69. India Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 70. India Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 71. India Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 72. India Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Tumor Markers Immunoassay Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Tumor Markers Immunoassay Market Share (2019-2020)
Table 75. Central & South America Tumor Markers Immunoassay Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Tumor Markers Immunoassay Market Share by Type (2015-2020)
Table 77. Central & South America Tumor Markers Immunoassay Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Tumor Markers Immunoassay Market Share by Application (2015-2020)
Table 79. Clarity Diagnostics, LLC Company Details
Table 80. Clarity Diagnostics, LLC Business Overview
Table 81. Clarity Diagnostics, LLC Product
Table 82. Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 83. Clarity Diagnostics, LLC Recent Development
Table 84. CTK Biotech, Inc Company Details
Table 85. CTK Biotech, Inc Business Overview
Table 86. CTK Biotech, Inc Product
Table 87. CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 88. CTK Biotech, Inc Recent Development
Table 89. DIALAB GmbH Company Details
Table 90. DIALAB GmbH Business Overview
Table 91. DIALAB GmbH Product
Table 92. DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 93. DIALAB GmbH Recent Development
Table 94. Ortho Clinical Diagnostics Company Details
Table 95. Ortho Clinical Diagnostics Business Overview
Table 96. Ortho Clinical Diagnostics Product
Table 97. Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 98. Ortho Clinical Diagnostics Recent Development
Table 99. Polymedco, Inc Company Details
Table 100. Polymedco, Inc Business Overview
Table 101. Polymedco, Inc Product
Table 102. Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 103. Polymedco, Inc Recent Development
Table 104. DIAsource ImmunoAssays SA Company Details
Table 105. DIAsource ImmunoAssays SA Business Overview
Table 106. DIAsource ImmunoAssays SA Product
Table 107. DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 108. DIAsource ImmunoAssays SA Recent Development
Table 109. DRG International, Inc Company Details
Table 110. DRG International, Inc Business Overview
Table 111. DRG International, Inc Product
Table 112. DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 113. DRG International, Inc Recent Development
Table 114. Fujirebio US, Inc Business Overview
Table 115. Fujirebio US, Inc Product
Table 116. Fujirebio US, Inc Company Details
Table 117. Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 118. Fujirebio US, Inc Recent Development
Table 119. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
Table 120. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
Table 121. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Product
Table 122. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 123. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
Table 124. Boson Biotech Co., Ltd Company Details
Table 125. Boson Biotech Co., Ltd Business Overview
Table 126. Boson Biotech Co., Ltd Product
Table 127. Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 128. Boson Biotech Co., Ltd Recent Development
Table 129. Qualigen, Inc Company Details
Table 130. Qualigen, Inc Business Overview
Table 131. Qualigen, Inc Product
Table 132. Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 133. Qualigen, Inc Recent Development
Table 134. Randox Laboratories, Ltd Company Details
Table 135. Randox Laboratories, Ltd Business Overview
Table 136. Randox Laboratories, Ltd Product
Table 137. Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 138. Randox Laboratories, Ltd Recent Development
Table 139. Roche Diagnostic Corporation Company Details
Table 140. Roche Diagnostic Corporation Business Overview
Table 141. Roche Diagnostic Corporation Product
Table 142. Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 143. Roche Diagnostic Corporation Recent Development
Table 144. Siemens Healthineers Company Details
Table 145. Siemens Healthineers Business Overview
Table 146. Siemens Healthineers Product
Table 147. Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 148. Siemens Healthineers Recent Development
Table 149. Syntron Bioresearch, Inc Company Details
Table 150. Syntron Bioresearch, Inc Business Overview
Table 151. Syntron Bioresearch, Inc Product
Table 152. Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 153. Syntron Bioresearch, Inc Recent Development
Table 154. Teco Diagnostics Company Details
Table 155. Teco Diagnostics Business Overview
Table 156. Teco Diagnostics Product
Table 157. Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 158. Teco Diagnostics Recent Development
Table 159. Thermo Fisher Scientific, Inc Company Details
Table 160. Thermo Fisher Scientific, Inc Business Overview
Table 161. Thermo Fisher Scientific, Inc Product
Table 162. Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 163. Thermo Fisher Scientific, Inc Recent Development
Table 164. Tosoh Bioscience, Inc Company Details
Table 165. Tosoh Bioscience, Inc Business Overview
Table 166. Tosoh Bioscience, Inc Product
Table 167. Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 168. Tosoh Bioscience, Inc Recent Development
Table 169. Diametra Company Details
Table 170. Diametra Business Overview
Table 171. Diametra Product
Table 172. Diametra Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 173. Diametra Recent Development
Table 174. DiaSorin S.p.A Company Details
Table 175. DiaSorin S.p.A Business Overview
Table 176. DiaSorin S.p.A Product
Table 177. DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2015-2020) (Million US$)
Table 178. DiaSorin S.p.A Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Markers Immunoassay Market Share by Type: 2020 VS 2026
Figure 2. ProGRP Features
Figure 3. PSA (complexed, free, total)) Features
Figure 4. SCC (squamous cell carcinoma antigen) Features
Figure 5. Serum HER-2/neu Features
Figure 6. Thyroglobulin Features
Figure 7. CA 72-4 Features
Figure 8. Others Features
Figure 9. Global Tumor Markers Immunoassay Market Share by Application: 2020 VS 2026
Figure 10. Liver Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Tumor Markers Immunoassay Report Years Considered
Figure 14. Global Tumor Markers Immunoassay Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Tumor Markers Immunoassay Market Share by Regions: 2020 VS 2026
Figure 16. Global Tumor Markers Immunoassay Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Tumor Markers Immunoassay Market Share by Players in 2019
Figure 19. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Markers Immunoassay as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Tumor Markers Immunoassay Revenue in 2019
Figure 21. North America Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Tumor Markers Immunoassay Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
シングルプレックスイムノアッセイの世界市場（～2026年） Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. The…- マルチプレックス検出イムノアッセイの世界市場（～2026年） Multiplex immunoassay development is ascribed to the expanding requirement for enhanced disease analytic procedures alongside the diminished costs and minimized errors. Growth of the global multiplex detection immunoassay market is expected to rise due to expanding geriatric population inclined to i…
- 免疫測定法の世界市場（～2026年） An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes). The molecule detected by the immunoassay is often referred to as an "analyte" and is in many cases…
- 腫瘍マーカー検査の世界市場（～2026年） The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagn…
- ウォッシャブルマーカーの世界市場（～2026年） Washable markers use food-coloring dyes, carboxylic acids and carboxylates, and a water-based solvent which prevents the color from sticking to surfaces. Market Analysis and Insights: Global Washable Markers Market The global Washable Markers market size is projected to reach US$ 373.4 million by 20…